Daiwa Securities Group
HZNP

Daiwa Securities Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Daiwa Securities Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,476
Closed -$2.02M – 1425
2023
Q3 		$2.02M Sell
17,476
-587
-3% -$63.1K 0.01% 494
2023
Q2 		$1.86M Sell
18,063
-250
-1% -$26.4K 0.01% 520
2023
Q1 		$2M Buy
18,313
+445
+2% +$49.2K 0.01% 494
2022
Q4 		$2.03M Buy
17,868
+825
+5% +$68.5K 0.02% 474
2022
Q3 		$1.05M Buy
17,043
+193
+1% +$13.5K 0.01% 620
2022
Q2 		$1.34M Buy
16,850
+640
+4% +$60.6K 0.01% 566
2022
Q1 		$1.71M Buy
16,210
+671
+4% +$65.4K 0.01% 549
2021
Q4 		$1.67M Buy
15,539
+145
+0.9% +$15.8K 0.01% 557
2021
Q3 		$1.69M Buy
15,394
+267
+2% +$27.7K 0.01% 539
2021
Q2 		$1.42M Buy
15,127
+545
+4% +$50.2K 0.01% 553
2021
Q1 		$1.34M Buy
14,582
+5,320
+57% +$449K 0.01% 536
2020
Q4 		$678K Buy
9,262
+8,026
+649% +$597K 0.01% 681
2020
Q3 		$96K Buy
1,236
+179
+17% +$12.3K ﹤0.01% 913
2020
Q2 		$32K Hold
1,057
– – ﹤0.01% 1000
2020
Q1 		$31K Hold
1,057
– – ﹤0.01% 982
2019
Q4 		$38K Sell
1,057
-131
-11% -$4.02K ﹤0.01% 977
2019
Q3 		$32K Buy
1,188
+25
+2% +$646 ﹤0.01% 978
2019
Q2 		$28K Buy
1,163
+84
+8% +$2.13K ﹤0.01% 993
2019
Q1 		$29K Buy
+1,079
New +$25.6K ﹤0.01% 977
2018
Q4 		– Sell
-906
Closed -$18K – 1218
2018
Q3 		$18K Hold
906
– – ﹤0.01% 1008
2018
Q2 		$15K Hold
906
– – ﹤0.01% 1027
2018
Q1 		$13K Buy
+906
New +$13.4K ﹤0.01% 1015

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Daiwa Securities Group's HZNP Position: Q4 2023 in Review

Daiwa Securities Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 17,476 shares — an estimated $2.02M sold.

Daiwa Securities Group first reported a position in HZNP in Q1 2018 and held it in 22 quarters. The position peaked at $2.03M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Daiwa Securities Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 17,476 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.02M.
  • Daiwa Securities Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 22 quarters.
  • Daiwa Securities Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.03M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.